CMT Research Foundation Partners to Study Inosine as CMT1X Therapy
The CMT Research Foundation is teaming up with the University of Illinois Chicago (UIC) to investigate a potential treatment for X-linked Charcot-Marie-Tooth type 1 disease (CMTX1), the second most common type of CMT. Together, they aim to test whether inosine, an anti-inflammatory molecule, might act in ways that…